polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax]
RxNorm concept 876214, branded drug (sbd). Prescribable name: GaviLAX 17 GM Powder for Oral Solution.
- RxCUI
- 876214
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/876214 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- polyethylene glycol 3350 17000 MG (SCDC, consists of)
- polyethylene glycol 3350 17000 MG [Gavilax] (SBDC, consists of)
- Powder for Oral Solution (DF, has dose form)
- Gavilax (BN, has ingredient)
- polyethylene glycol 3350 17000 MG Powder for Oral Solution (SCD, tradename of)
Linked data
NDCs
- 17856031001
- 17856031002
- 17856031201
- 17856031202
- 17856031203
- 17856031204
- 17856031205
- 17856031206
- 17856031207
- 17856031208
- 17856031209
- 43386031207
- 43386031208
- 43386031214
- 43386031285
- 50090531000
- 61919054251
- 63187036823
- 68788750802
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 876214 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/876214 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 876214. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.